Catalent files registration statement for initial public offering
Net proceeds will be used to repay debt, with any remainder to be used for general corporate purposes
Catalent Inc., the parent company of Catalent Pharma Solutions, has publicly filed a registration statement with the US Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
The number of shares to be offered and the price range for the proposed offering have not yet been determined. The company intends to use the net proceeds from the offering to repay debt, with any remaining balance to be used for general corporate purposes.
